Differential effects of nephrotoxic agents on renal transport and metabolism by use of in vitro techniques.

od Hirsch, G H
Wydane 1976

RURAL-URBAN BALANCE IN A REGIONAL FRAMEWORK.

od HIRSCH, G. P.
Wydane S1970

Narcotics and the community: a system stimulation.

od Levin, G, Hirsch, G, Roberts, E
Wydane 1972

Inhibition of vein graft intimal proliferative lesions in the rat by heparin.

od Hirsch, G. M., Karnovsky, M. J.
Wydane 1991

Evidence of a codon restriction hypothesis of cellular differentiation: multiplicity of mammalian leucyl-sRNA-specific synthetases and tissue-specific deficiency in an alanyl-sRNA...

od Strehler, B L, Hendley, D D, Hirsch, G P
Wydane 1967

Glycine uptake by the proteins of the rat pancreatic juice

od Junqueira, L. C. U., Hirsch, G. C., Rothschild, H. A.
Wydane 1955

Accuracy of injection and short-term pain relief following intra-articular corticosteroid injection in knee osteoarthritis – an observational study

od Hirsch, G., O’Neill, T. W., Kitas, G., Sinha, A., Klocke, R.
Wydane w BMC Musculoskelet Disord (2017)

A219 HEPATITIS C IN NOVA SCOTIA PATIENTD WITH HEREDITARY BLEEDING DISORDERS: AUDIT FOR IDENTIFICATION OF PATIENTS FOR POTENTIAL TREATMENT WITH DIRECT ACTING ANTIVIRAL AGENTS

od Alahmadi, A, Mishra, S, Hirsch, G, carla, B, Robinson, K, Peltekian, K M
Wydane w J Can Assoc Gastroenterol (2018)

A49 INNOVATIVE GROUP EDUCATION FOR A COMMON LIVER DISEASE - INCREASING ACCESS TO CARE

od Laryea, M, McLeod, M, Peltekian, K M, Sabharwal, A, Hirsch, G, Burgess, C
Wydane w J Can Assoc Gastroenterol (2018)

Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivo.

od Pukac, L. A., Hirsch, G. M., Lormeau, J. C., Petitou, M., Choay, J., Karnovsky, M. J.
Wydane 1991

Reduced in vivo high-energy phosphates precede Adriamycin-induced cardiac dysfunction

od Maslov, M. Y., Chacko, V. P., Hirsch, G. A., Akki, A., Leppo, M. K., Steenbergen, C., Weiss, R. G.
Wydane 2010

The next frontier: Fostering innovation by improving health data access and utilization

od Oye, KA, Jain, G, Amador, M, Arnaout, R, Brown, JS, Crown, W, Ferguson, J, Pezalla, E, Rassen, JA, Selker, HP, Trusheim, M, Hirsch, G
Wydane w Clin Pharmacol Ther (2015)

Adaptive Biomedical Innovation: Evolving Our Global System to Sustainably and Safely Bring New Medicines to Patients in Need

od Hirsch, G, Trusheim, M, Cobbs, E, Bala, M, Garner, S, Hartman, D, Isaacs, K, Lumpkin, M, Lim, R, Oye, K, Pezalla, E, Saltonstall, P, Selker, H
Wydane w Clin Pharmacol Ther (2016)

Corrigendum: Adaptive biomedical innovation: Evolving our global system to sustainably and safely bring new medicines to patients in need

od Hirsch, G, Trusheim, M, Cobbs, E, Bala, M, Garner, S, Hartman, D, Isaacs, K, Lumpkin, M, Lim, R, Oye, K, Pezalla, E, Saltonstall, P, Selker, H
Wydane w Clin Pharmacol Ther (2017)

A261 DIRECT ACTING ANTIVIRAL THERAPY IS EFFECTIVE IN RECURRENT HEPATITIS C IN BOTH TREATMENT NAIVE AND EXPERIENCED LIVER TRANSPLANT RECIPIENTS: CLINICAL AUDIT OF THE ATLANTIC MULTI...

od Hirsch, G, Miles, M, Peltekian, S E, Kiberd, J, Brown, B I, O’Brien, M, Leonard, J, McKnight, L C, McLeod, M, Laryea, M, Peltekian, K M
Wydane w J Can Assoc Gastroenterol (2018)

From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients

od Eichler, H‐G, Baird, LG, Barker, R, Bloechl‐Daum, B, Børlum‐Kristensen, F, Brown, J, Chua, R, Del Signore, S, Dugan, U, Ferguson, J, Garner, S, Goettsch, W, Haigh, J, Honig, P, Hoos, A, Huckle, P, Kondo, T, Le Cam, Y, Leufkens, H, Lim, R, Longson, C, Lumpkin, M, Maraganore, J, O'Rourke, B, Oye, K, Pezalla, E, Pignatti, F, Raine, J, Rasi, G, Salmonson, T, Samaha, D, Schneeweiss, S, Siviero, PD, Skinner, M, Teagarden, JR, Tominaga, T, Trusheim, MR, Tunis, S, Unger, TF, Vamvakas, S, Hirsch, G
Wydane w Clin Pharmacol Ther (2015)